| Literature DB >> 21489994 |
Ken Nakamura1, Venu M Nemani, Farnaz Azarbal, Gaia Skibinski, Jon M Levy, Kiyoshi Egami, Larissa Munishkina, Jue Zhang, Brooke Gardner, Junko Wakabayashi, Hiromi Sesaki, Yifan Cheng, Steven Finkbeiner, Robert L Nussbaum, Eliezer Masliah, Robert H Edwards.
Abstract
The protein α-synuclein has a central role in Parkinson disease, but the mechanism by which it contributes to neural degeneration remains unknown. We now show that the expression of α-synuclein in mammalian cells, including neurons in vitro and in vivo, causes the fragmentation of mitochondria. The effect is specific for synuclein, with more fragmentation by α- than β- or γ-isoforms, and it is not accompanied by changes in the morphology of other organelles or in mitochondrial membrane potential. However, mitochondrial fragmentation is eventually followed by a decline in respiration and neuronal death. The fragmentation does not require the mitochondrial fission protein Drp1 and involves a direct interaction of synuclein with mitochondrial membranes. In vitro, synuclein fragments artificial membranes containing the mitochondrial lipid cardiolipin, and this effect is specific for the small oligomeric forms of synuclein. α-Synuclein thus exerts a primary and direct effect on the morphology of an organelle long implicated in the pathogenesis of Parkinson disease.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21489994 PMCID: PMC3121472 DOI: 10.1074/jbc.M110.213538
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157